CLDI - Calidi Biotherapeutics, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.59 0.13 (8.18%)	---	---	0.01 (0.58%)	0.08 (5.05%)	-0.01 (-0.6%)	0.06 (3.61%)	0.06 (3.61%)

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.99
Diluted EPS:: -1.99
Basic P/E:: -0.8643
Diluted P/E:: -0.8643
RSI(14) 1m:: 100.0
VWAP:: 1.72
RVol:: 1.0886

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.71 -0.03 (-1.72%)	Oct 15 18:46
60m	Price increase 60m	1.75 +0.09 (+5.42%)	Oct 15 18:43
Day	Price increase day	1.75 +0.16 (+10.06%)	Oct 15 18:43
1m	Price decrease 1m	1.66 -0.02 (-1.19%)	Oct 15 15:59
1m	Price decrease 1m	1.63 -0.04 (-2.4%)	Oct 15 15:55